Ekso Bionics CFO Jack Glenn resigns; Controller Jerome Wong named Interim CFO

EKSO BIONICS HOLDINGS, INC.

CFO Jack Glenn resigns effective June 17, 2022, to join another public company; no dispute or disagreement.
Jerome Wong, company Controller since May 2017, appointed Interim CFO effective June 17, 2022.
Wong's salary increased from $212,000 to $265,000; target bonus set at 50% of base salary.
Wong to receive RSU award valued at $150,000, vesting over three years from June 17, 2022.
Compensation Committee awards 300,000 RSUs to President & COO Scott Davis for his January 2022 promotion.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John F. Glenn

Chief Financial Officer

CHRN · EKSO BIONICS HOLDINGS, INC.

Effective: 2022-06-17
Successor: Jerome Wong
Filed: May 26, 2022, 7:59 PM ET

John F. Glenn notified Ekso Bionics Holdings, Inc. (the “Company”) of his decision to resign from his position as the Company’s Chief Financial Officer, effective June 17, 2022, in connection with his retention as an employee at another public company.

Appointed (interim)

Jerome Wong

Interim Chief Financial Officer

CHRN · EKSO BIONICS HOLDINGS, INC.

Effective: 2022-06-17
Filed: May 26, 2022, 7:59 PM ET

the Company’s board of directors (the “Board”) approved the appointment of Jerome Wong as Interim Chief Financial Officer, effective upon Mr. Glenn’s departure.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John F. Glenn resigned as Chief Financial Officer at EKSO BIONICS HOLDINGS, INC..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

John F. Glenn notified Ekso Bionics Holdings, Inc. (the “Company”) of his decision to resign from his position as the Company’s Chief Financial Officer, effective June 17, 2022, in connection with his retention as an employee at another public company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jerome Wong was appointed as Interim Chief Financial Officer at EKSO BIONICS HOLDINGS, INC..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

the Company’s board of directors (the “Board”) approved the appointment of Jerome Wong as Interim Chief Financial Officer, effective upon Mr. Glenn’s departure.

View on SEC.gov

EKSO BIONICS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-064932

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.